Literature DB >> 24746545

Increased serum level of CTRP1 is associated with low coronary collateralization in stable angina patients with chronic total occlusion.

Ying Shen1, Lin Lu1, Zhu Hui Liu2, Feng Wu3, Jin Zhou Zhu2, Zhen Sun1, Rui Yan Zhang1, Qi Zhang1, Jian Hu1, Qiu Jing Chen2, Zong Gui Wu4, Wei Feng Shen5.   

Abstract

Entities:  

Keywords:  C1q TNF related protein; Chronic total occlusion; Coronary artery disease; Coronary collateral circulation; Endothelial progenitor cell

Mesh：

Substances：

Year:  2014        PMID： 24746545     DOI： 10.1016/j.ijcard.2014.03.205

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  12 in total

1.  Loss of CTRP1 disrupts glucose and lipid homeostasis.

Authors:  Susana Rodriguez; Xia Lei; Pia S Petersen; Stefanie Y Tan; Hannah C Little; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-23       Impact factor: 4.310

2.  Aging and chronic high-fat feeding negatively affect kidney size, function, and gene expression in CTRP1-deficient mice.

Authors:  Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Paride Fenaroli; Stefanie Y Tan; Dylan C Sarver; Michael Delannoy; C Conover Talbot; Sandeep Jandu; Dan E Berkowitz; Jennifer L Pluznick; Avi Z Rosenberg; G William Wong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-21       Impact factor: 3.619

3.  Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

Authors:  Ying Shen; Feng Hua Ding; Rui Yan Zhang; Qi Zhang; Lin Lu; Wei Feng Shen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

4.  Serum levels of C1q/TNF-related protein-1 (CTRP-1) are closely associated with coronary artery disease.

Authors:  Huizhong Wang; Ru Wang; Dayong Du; Fangliang Li; Yuntian Li
Journal:  BMC Cardiovasc Disord       Date:  2016-05-11       Impact factor: 2.298

Review 5.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

6.  Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Zhen Kun Yang; Jian Hu; Xiao Qun Wang; Yang Dai; Su Zhang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-06-01       Impact factor: 9.951

7.  Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Shuai Chen; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Zhen Kun Yang; Jian Hu; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2019-06-24       Impact factor: 9.951

Review 8.  Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease.

Authors:  Ying Shen; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2019-11-16       Impact factor: 9.951

9.  Late-onset renal hypertrophy and dysfunction in mice lacking CTRP1.

Authors:  Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Blythe D Shepard; Stefanie Y Tan; Andrew Wolfe; Muhammad Umar Cheema; Sandeep Jandu; Owen M Woodward; C Conover Talbot; Dan E Berkowitz; Avi Z Rosenberg; Jennifer L Pluznick; G William Wong
Journal:  FASEB J       Date:  2019-12-26       Impact factor: 5.191

10.  Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21.

Authors:  Sora Han; Jong Dai Kim; Sunyi Lee; Ae Lee Jeong; Jeong Su Park; Hyo Jeong Yong; Ariundavaa Boldbaatar; Hye In Ka; Eun-Jung Rhee; Won-Young Lee; Young Yang
Journal:  Int J Endocrinol       Date:  2016-05-23       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.